Ovarian PRP: Scientific Facts for Low AMH & Poor Reserve Patients
How platelet-rich plasma (PRP) and stem cell therapies rejuvenate ovarian tissue at the cellular level. Who qualifies, and what results to expect.
Diminished ovarian reserve (DOR), characterised by a low antral follicle count (AFC) and reduced Anti-Müllerian hormone (AMH), affects approximately 10% of women seeking fertility treatment. Conventional IVF protocols often yield poor results in this group. Platelet-Rich Plasma (PRP) ovarian rejuvenation—pioneered in Greece and now offered at Meva Clinic Cyprus—represents a scientifically substantiated adjuvant therapy that may restore follicular activity in previously non-responsive ovaries. This rejuvenation protocol is one of the Cyprus IVF options that can be discussed during consultation.
Ready to start your journey?
Free consultation · 24h response
The Cellular Mechanism of PRP
PRP contains concentrated growth factors (PDGF, TGF-β, VEGF, IGF-1) derived from the patient's own blood. When injected directly into the ovarian cortex under ultrasound guidance, these factors stimulate granulosa cell proliferation, improve local vascularisation, and may activate dormant primordial follicles. A 2022 landmark study (Sfakianoudis et al., J Clin Med) demonstrated AMH increases of 35–120% at 3-month follow-up in a cohort of 60 poor-responder patients.
Who Is a Candidate?
PRP is indicated for patients with: AMH < 0.5 ng/mL; AFC < 4; two or more failed IVF cycles due to poor response; premature ovarian insufficiency (POI) before natural menopause. It is contraindicated in active ovarian malignancy, platelet disorders, or ongoing anticoagulant therapy.
The Meva Protocol — Clinical Case Tone
A 39-year-old patient from Bucharest arrived at Meva Clinic Cyprus with AMH 0.18 ng/mL and AFC of 2 following two failed IVF cycles in Romania. Post-PRP (two sessions, 6 weeks apart), her AMH rose to 0.61 ng/mL and AFC to 5. A subsequent stimulated IVF cycle yielded 3 mature oocytes and resulted in a successful blastocyst transfer. This outcome, while not guaranteed, reflects the potential of PRP in appropriately selected patients.
Frequently Asked Questions
How is ovarian PRP performed?+
How soon can I start IVF after PRP?+
What is the cost of ovarian PRP at Meva Clinic?+
Is PRP evidence-based?+
Can stem cells be combined with PRP?+
Reviewed by
Meva Clinic Medical Review Board
Clinical Governance & Specialist Pathway Standards
This page has been reviewed under Meva Clinic’s specialist medical review pathway. Final treatment suitability, operating physician assignment, surgical planning, and medical decisions are confirmed only after medical history review, in-person consultation, diagnostic tests, anesthesia evaluation, and doctor availability.
Ready for a deeper evaluation?
Consult with our board regarding this specific topic.
Partner Hospital Quality & Medical Network Standards
Accreditation and society references relate to selected partner hospitals, provider institutions, or individual partner surgeons where applicable. Meva Clinic coordinates international patient care through licensed healthcare providers and specialist medical partners.